Zhuo Li

Title: Innovations of Inventor Zhuo Li

Introduction

Zhuo Li is an accomplished inventor based in Hefei, China. He has made significant contributions to the field of protein inhibitory medicines. His innovative work focuses on the use of compounds to inhibit AIM2 protein activity, which has important implications for medical treatments.

Latest Patents

Zhuo Li holds a patent for the use of a compound or medicinal derivative in inhibiting AIM2 protein activity. This patent highlights a compound that demonstrates a strong targeting effect compared to traditional broad-spectrum immunomodulators. The compound is noted for its accuracy, rapid action, effectiveness, safety, and stability. It exhibits a strong binding force with both human and mouse AIM2 proteins, with binding constants as high as K=1.56EM and K=5.12EM, respectively. Additionally, the compound offers advantages such as easy storage, stable activity, small molecular weight, lower production cost, and easy absorption.

Career Highlights

Zhuo Li is associated with Liangdan Sun, a company that supports his innovative research. His work has positioned him as a notable figure in the field of protein inhibitors, contributing to advancements in targeted therapies.

Collaborations

Zhuo Li collaborates with colleagues, including Qi Zhen and Liangdan Sun, who contribute to his research endeavors.

Conclusion

Zhuo Li's innovative work in the field of protein inhibitory medicines showcases his commitment to advancing medical science. His patent reflects a significant step forward in targeted therapies, emphasizing the importance of precision in medical treatments.